Biodesix, Inc. BDSX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -26%+5.5pp | -31.5%+9.1pp | -40.6%+3.9pp | -44.5%-0.7pp | -43.8%+4.6pp | |
| Net margin | -33.3%+6.6pp | -39.8%+9.5pp | -49.3%+4.3pp | -53.7%+0.6pp | -54.3%+5.9pp | |
| EBITDA margin | -20.1%+5.0pp | -25.1%+8.4pp | -33.5%+3.5pp | -36.9%-0.9pp | -36%+4.3pp | |
| Free cash flow margin | -26.8%+0.5pp | -27.4%+9.0pp | -36.4%+4.3pp | -40.7%+19.8pp | -60.4%+12.3pp | |
| Returns | ||||||
| Return on equity | -316.5%— | —— | —— | -219.7%— | —— | |
| Return on assets | -35.3%+2.8pp | -38.2%+3.1pp | -41.3%-0.9pp | -40.4%+6.3pp | -46.6%-2.9pp | |
| Return on invested capital | -45%+6.6pp | -51.6%+6.0pp | -57.6%+5.4pp | -63%+2.3pp | -65.3%+6.9pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.1× | 1×+0.1× | 0.8×+0.1× | 0.8×-0.1× | 0.9×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.8×+1.0× | 1.9×0.0× | 1.8×-0.3× | 2.1×-0.1× | 2.2×-0.5× | |
| Quick ratio | 2.8×+1.0× | 1.9×0.0× | 1.8×-0.3× | 2.1×-0.1× | 2.2×-0.5× | |
| Cash ratio | 1.8×+0.7× | 1.1×+0.2× | 0.9×-0.5× | 1.4×0.0× | 1.3×-0.5× | |
| Leverage | ||||||
| Debt-to-equity | 7.8×— | —— | —— | 63.4×+57.7× | 5.6×+2.7× | |
| Debt-to-assets | 0.8×-0.1× | 0.8×0.0× | 0.8×0.0× | 0.8×+0.1× | 0.7×+0.1× | |
| Interest coverage | -3.1×+0.5× | -3.6×+0.8× | -4.4×+0.2× | -4.6×-0.2× | -4.4×-0.2× | |
| Per Share | ||||||
| Book value per share | $0.95+390% | -$0.33-42.2% | -$0.23-3,044% | $0.01-99.5% | $1.52-53.0% | |
| Valuation | ||||||
| Market capitalization | $233.52M+476% | $54.1M-10.4% | $60.4M+49.7% | $40.33M-55.8% | $91.27M-59.0% | |
| Enterprise value | $279.56M+204% | $107.96M-7.5% | $116.71M+27.2% | $91.73M-32.5% | $135.93M-47.4% | |
| Price / sales | 2.4×+1.9× | 0.6×-0.1× | 0.8×+0.2× | 0.5×-0.7× | 1.2×-1.9× | |
| Price / book | 25.6×-10.1× | —— | —— | 35.4×+27.2× | 8.3×-2.4× | |
| EV / sales | 2.9×+1.7× | 1.2×-0.2× | 1.5×+0.3× | 1.2×-0.6× | 1.8×-1.8× | |
| Free cash flow yield | -11%+65.7pp | -44.8%+3.5pp | -48.3%+28.9pp | -77.2%-27.9pp | -49.3%-26.0pp | |
| Earnings yield | -13.7%+87.6pp | -65.2%+0.3pp | -65.5%+36.4pp | -101.8%-57.6pp | -44.3%-25.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Biodesix, Inc.'s ratios come from?
- Every ratio is computed from Biodesix, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
